Navigation Links
Neogen Launches Fully Quantitative Lateral Flow Test for Aflatoxin
Date:9/22/2011

LANSING, Mich., Sept. 22, 2011 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) has developed a quick and easy new test for aflatoxin, a toxin considered by many to be the most potent, naturally-occurring carcinogen. The toxin is a by-product of mold growth in a wide range of commodities, including corn. Because it is a known severe threat to human and animal health, more than 100 countries have established regulatory limits for aflatoxin in commodities intended as human food or animal feed.

Neogen's new Reveal® Q+ for Aflatoxin combines the speed and simplicity of a lateral flow screening test, like a home pregnancy test, with the fully quantitative precision of a more demanding testing method. The new test delivers precise results ranging from 2 to 150 parts per billion (ppb) of aflatoxin after only 6 minutes.

"Reveal Q+ for Aflatoxin is the easiest test available for rapid, fully quantitative test results, and uses a more environmentally friendly ethanol extraction," said Ed Bradley, Neogen's vice president for Food Safety. "This innovative technology yields more accurate and reproducible results. Coupled with Neogen's AccuScan III reader, the Reveal Q+ system objectively reads, analyzes and stores test results.

"Reveal Q+ for Aflatoxin is the first in our new line of fully quantitative lateral flow tests for mycotoxins," Bradley continued. "Tests for DON and zearalenone are in the final stages of development. The new Reveal Q+ products add to Neogen's unmatched range of simple and accurate lateral flow, microwell, immunoaffinity column mycotoxin testing options — all of which are backed by the best technical and R&D support in the industry."

Reveal Q+ for Aflatoxin offers both room temperature incubation of the test strip and storage of the test kit — eliminating the need for an incubator and refrigeration space. The test requires only minimal equipment to achieve precise results and a simple low cost ethanol extraction process. Ethanol is the preferred extract solvent of some major grain handlers.

Neogen's AccuScan® III reader provides an easy method to objectively read, store, and analyze results from Neogen's line of lateral flow tests. AccuScan provides a permanent result that can be incorporated into a company's food safety plan, such as HACCP.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.


'/>"/>
SOURCE Neogen Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Webcast Alert: Neogen Corporation to Announce 1st Quarter Results
2. Neogen Reports 26% Increase in Revenues
3. Neogen Honored by Forbes; Two Brokerage Firms Initiate Coverage
4. NeoGenomics to Present at the Rodman & Renshaw Healthcare Conference on November 10
5. Neogen Announces New Share Repurchase Program
6. Neogen Reports Best Quarter in Its 26-Year History
7. Neogens BetaStar(R) US Dairy Antibiotic Test Approved by FDA/NCIMS
8. Neogen Named Supplier of Chr. Hansen Probiotics for Swine and Poultry
9. Neogen Names New Senior Science Officer; Added to S&P Index
10. NeoGenomics Schedules its Q4 and Full Year 2008 Earnings Release for March 5, 2009
11. NeoGenomics Announces Fourth Quarter and Full Year 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers use ... 6000i models are higher end machines that use the more unconventional z-dimension of 20mm. ... from the bottom of the cuvette holder. , FireflySci has developed several Agilent ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. ... test has received AOAC Research Institute approval 061601. , “This is another AOAC-RI ... stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, ... of the Supplyframe Design Lab . Located in Pasadena, Calif., the Design ... of how hardware projects are designed, built and brought to market. , The ...
Breaking Biology Technology:
(Date:6/16/2016)... June 16, 2016 The ... expected to reach USD 1.83 billion by 2024, ... Research, Inc. Technological proliferation and increasing demand in ... expected to drive the market growth. ... The development of advanced multimodal techniques for ...
(Date:6/3/2016)... 2016 Das DOTM ... Nepal hat ein 44 Millionen ... Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an ... und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale ... teilgenommen, aber Decatur wurde als konformste und ...
(Date:5/24/2016)... superior patient care by providing unparalleled technology to leaders of the medical imaging industry. ... recently added to the range of products distributed by Ampronix. Photo - ... ... ... ...
Breaking Biology News(10 mins):